Snowflake Faces Analyst Price Target Adjustments Ahead of Earnings Report London Stock Exchange Group Reports Income Growth Led by Tradeweb Platform Burberry Shares Surge on Moncler Takeover Speculation Economic Costs of Education Bans A Human Capital Flight Story from Afghanistan New EV Brand Backed by Five Companies Targets Japans Mini Car Market India Diversifies Oil Imports Amid Hormuz Disruption Turns to Latin America and Africa VUZI Q1 2026 Earnings Narrowed Loss Surprises Revenue Remains Absent Pathward Financial CASH Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly LPL Financial Q1 2026 Earnings Slight EPS Beat Amid Market Headwinds HubSpot Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed ZEPP Q3 2025 Earnings Narrowed Loss Amid Mixed Operational Signals SERV Q1 2026 Earnings PreRevenue Robotics Company Misses EPS Estimates as Losses Widen Voya Infrastructure Industrials and Materials Fund IDE Retreats 108 as Price Nears Key Support FirstService Corporation FSV Holds Steady Near Support as Sector Headwinds Persist STRD Preferred Stock Holds Steady Near Support as Trading Remains Muted Amplitech Group Inc Series B Right AMPGZ Faces Sharp Decline as Key Support Test Looms Alaska Air Group ALK Tests Key Resistance as Travel Demand Stabilizes Cancer Treatment Costs Soar ACA Could Have Eased Burden Survivor Suggests CPSH Q1 2026 Earnings EPS Misses Estimates Stock Rises Over 28 FG Imperii Acquisition Corp Units FGIIU Slip 050 as Units Trade Near Support Level Adobe ADBE Q1 2026 Earnings EPS Beats Estimates Slightly Market Reaction Muted FITBI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency YMM Q1 2026 Earnings Strong EPS Beat Masks Revenue Concerns as Stock Slips Canopy Growth CGC Q1 2026 Earnings Deep Loss Widens as Cannabis Operator Faces Margin Pressures STKE Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises on Strategic Optimism General Motors Q1 2026 Earnings Strong EPS Beat Drives Stock Higher NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline